Gabriel Siracusano

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 6

Top Topics

Endothelial Cells

Respiratory Syndrome Coronavirus

Endoplasmic Reticulum

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Diego Cantoni, Gabriel Siracusano, Martin Mayora Neto, Claudia Pastori, Tobia Fantoni, Spyros Lytras, Cecilia Di Genova, Joseph Hughes, null On Behalf Of The Ambulatorio Medico San Luca Villanuova Group, Lopalco Lucia, Nigel J Temperton
Analysis of Antibody Neutralisation Activity against SARS-CoV-2 Variants and Seasonal Human Coronaviruses NL63, HKU1, and 229E Induced by Three Different COVID-19 Vaccine Platforms. Vaccines 11 (1) (2022)
Diego Cantoni, Gabriel Siracusano, Martin Mayora Neto, Claudia Pastori, Tobia Fantoni, Spyros Lytras, Cecilia Di Genova, Joseph Hughes, null On Behalf Of The Ambulatorio Medico San Luca Villanuova Group, Lopalco Lucia, Nigel J Temperton
Analysis of Antibody Neutralisation Activity against SARS-CoV-2 Variants and Seasonal Human Coronaviruses NL63, HKU1, and 229E Induced by Three Different COVID-19 Vaccine Platforms. Vaccines 11 (1) (2022)
Diego Cantoni, Gabriel Siracusano, Martin Mayora Neto, Claudia Pastori, Tobia Fantoni, Spyros Lytras, Cecilia Di Genova, Joseph Hughes, null On Behalf Of The Ambulatorio Medico San Luca Villanuova Group, Lopalco Lucia, Nigel J Temperton
Analysis of Antibody Neutralisation Activity against SARS-CoV-2 Variants and Seasonal Human Coronaviruses NL63, HKU1, and 229E Induced by Three Different COVID-19 Vaccine Platforms. Vaccines 11 (1) (2022)
Diego Cantoni, Gabriel Siracusano, Martin Mayora Neto, Claudia Pastori, Tobia Fantoni, Spyros Lytras, Cecilia Di Genova, Joseph Hughes, null On Behalf Of The Ambulatorio Medico San Luca Villanuova Group, Lopalco Lucia, Nigel J Temperton
Analysis of Antibody Neutralisation Activity against SARS-CoV-2 Variants and Seasonal Human Coronaviruses NL63, HKU1, and 229E Induced by Three Different COVID-19 Vaccine Platforms. Vaccines 11 (1) (2022)
Gabriel Siracusano, Lopalco Lucia
Immunotherapy with Cell-Based Biological Drugs to Cure HIV-1 Infection. Cells 11 (1) (2021)
Géraldine Vilmen, Damien Glon, Gabriel Siracusano, Marion Lussignol, Zhouwulin Shao, Eva Hernandez, Daniel Perdiz, Frédérique Quignon, Lina Mouna, Christian Poüs, Henri Gruffat, Vincent Maréchal, Audrey Esclatine
BHRF1, a BCL2 viral homolog, disturbs mitochondrial dynamics and stimulates mitophagy to dampen type I IFN induction. Autophagy 17 (6) (2020)